• Record: found
  • Abstract: not found
  • Article: not found

ROBUST: First report of phase III randomized study of lenalidomide/R-CHOP (R2 -CHOP) vs placebo/R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma

Read this article at

      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Related collections

      Author and article information

      [1 ]Division of Hematology; A.O.U. Città della Salute e della Scienza Hospital and University; Torino Italy
      [2 ]Division of Hematology; Mayo Clinic; Rochester MN United States
      [3 ]Centre for Lymphoid Cancer; British Columbia Cancer; Vancouver BC Canada
      [4 ]Harbin Medical University Cancer Hospital; Harbin Heilongjiang China
      [5 ]Department of Hematology; Jagiellonian University; Krakow Poland
      [6 ]Department of Hematology; Ankara University; Ankara Turkey
      [7 ]Cancer Hospital; Fudan University; Shanghai China
      [8 ]Beijing Cancer Hospital; Beijing China
      [9 ]The First Affiliated Hospital of Medical School of Zhejiang University; First Hospital of Zhejiang Province; Zhejiang Hangzhou China
      [10 ]Fourth Department of Internal Medicine-Hematology; Charles University Hospital and Faculty of Medicine; Hradec Králové Czech Republic
      [11 ]Servicio de Hematologia; Hospital Universitario San Pedro de Alcántara; Cáceres Spain
      [12 ]Division of Hematology, Department of Medicine; University of Padova and Azienda Ospedaliera di Padova; Padova Italy
      [13 ]Department of Internal Medicine and Haematology; Faculty Hospital Kralovske Vinohrady; Prague Czech Republic
      [14 ]UO Ematologia; Ospedale Degli Infermi; Rimini Italy
      [15 ]Department of Oncology, Asan Medical Center; University of Ulsan College of Medicine; Seoul South Korea Republic of Korea
      [16 ]AOU Città della Salute e della Scienza di Torino; Turin Italy
      [17 ]U.O. Ematologia, Dipartimento Oncologia e Ematologia; Ospedale Santa Maria delle Croci; Ravenna Italy
      [18 ]National Cancer Center Hospital; Tokyo Japan
      [19 ]Department of Medicine and Biosystemic Science; Kyushu University Faculty of Medicine; Fukuoka City Japan
      [20 ]Clinical Research & Development; Celgene Corporation; Summit NJ USA
      Hematological Oncology
      Hematol Oncol
      June 2019
      June 2019
      June 12 2019
      : 37
      : 36-37
      © 2019


      Comment on this article